TFAM and ovarian cancer: Gabrielson et al. [55] found that expression of PGC1α (proliferator-activated receptor gamma co-activator-1α) and TFAM (mitochondrial transcription factor A) might be employed as putative markers of chemoresistance in ovarian cancer.